FDA’s draft guidance outlines a flexible approach that, under certain circumstances, allows applicants and manufacturers to replace a color additive in an approved or marketed drug product with one ...

Color additives used in drug products must conform to FDA regulations and be properly listed and approved for the specific use. While a qualitative or quantitative change in inactive ingredients is ...